NCT06617416 2025-03-12A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLCAkesoPhase 3 Recruiting560 enrolled
NCT05940532 2023-07-11A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLCHunan Cancer HospitalPhase 2 Recruiting41 enrolled